DAYS
20+
SPEAKERS
30+
SESSION
80+
ATTENDANCE
As India Pharma Inc continues to expand and progress, elevating its position in the global pharma market necessitates an environment which fosters innovation, facilitates collaborative strategies and newer operating business models. And, this calls for concerted efforts from all stakeholders of the industry.
So, the overarching theme for this year's 'Pharma Summits' is 'Co-creating an ecosystem for pharma innovation'.
Organised by Express Pharma, these events will explore and examine factors influencing the pharma ecosystem and focus on crucial areas such as cost competitiveness, advancements in scientific research, creating new capabilities and skills, adapting to new regulations, leveraging emerging technologies for better outcomes etc.
The Sixth pharma summit of the year is the Chennai Pharma Summit, following the success of Vadodara Pharma Summit in October, Goa Pharma Summit in September, Aurangabad Pharma Summit in August, Bengaluru Pharma Summit in June, and the Ahmedabad Pharma Summit in April of FY 2024 –25.
Tamil Nadu’s pharmaceutical sector is undergoing a dynamic transformation, with Chennai at the core of these advancements. With a rich legacy in pharma education and manufacturing, the state is positioned to reclaim its leadership within India’s pharma industry. Today, it is home to over 400 licensed pharma units, primarily MSMEs engaged in contract manufacturing, the state is making significant strides to enhance its role in this high-growth sector with immense potential.
One of the most promising developments is the upcoming Pharma Park at Tindivanam in Villupuram district. This facility, spanning 111 acres, is set to host nearly 40 pharma units. Out of these, approximately 10-15 will be new entrants venturing into state for the first time, while the remaining will be expansion projects from companies already established in the state. This park is anticipated to generate pharmaceutical products worth `2,000 crore annually, marking a significant milestone in the state’s production capacity.
Additionally, the state government has also launched the Research & Development Policy 2022 and the Life Sciences Promotion Policy 2022, aiming to attract `20,000 crore in investment and create 50,000 jobs by 2030. It is also setting up a 350-acre medical devices park at the SIPCOT industrial complex in Oragadam, in Kancheepuram district poised to attract investments of `3,500 crore, further reinforcing the ecosystem for life sciences innovation in the state.
As part of this growth narrative, Express Pharma is organising the inaugural edition of “Chennai Pharma Summit’s” on December 20, 2024, at Chennai.
As Tamil Nadu aims to reclaim its leadership position in India’s pharma sector and propel forward as a key player in the global life sciences industry. The Chennai Pharma Summit promises to be an informative as well as knowledge driven conference, fostering collaboration, ideal knowledge exchange platform, and strategic insights sharing forum for like minded experts.
Strategic location
Chennai’s coastal advantage and connectivity to key domestic and international markets make it a strategic hub for pharma exports and supply chain integration
Government support
Tamil Nadu’s proactive policies, including the PLI scheme and Life Sciences Promotion Policy, provide a robust foundation for investment in Life sciences
Allied industries ecosystem
with strong linkages to chemicals, biotechnology, and engineering sectors, chennai offers a supportive network for pharma companies
Infrastructure readiness
The city is equipped with industrial parks, transportation networks, and power facilities essential for large-scale pharma manufacturing and R&D
Cost efficiency
Competitive land and operational costs make Chennai a cost-effective choice for life sciences businesses
Skilled talent pool
Chennai’s renowned educational institutions and research centers supply a steady stream of skilled professionals to the industry
Regulatory framework
A well-defined regulatory landscape ensures smooth operations and compliance with stringent global standards, promoting Tamil Nadu as an attractive location for pharma ventures
Industry insights on investment opportunities in Tamil Nadu’s pharma landscape
Global trends and their impact on domestic pharma
Review of government policies for pharma companies in Tamil Nadu
Evolving role of technology integration in enhancing manufacturing and quality assurance
Building a resilient pharma ecosystem
Identifying government initiatives and fostering growth and investment in the industry
Strategies for implementing sustainable practices in pharma manufacturing
Role of collaboration for innovation
Future frontiers: Biopharma and biosimilars
Chairman, IDMA (Tamilnadu, Puduchery and Kerala)
MD, Fourrts India
ED & CSO, Axxelent Pharma Science
VP and Head R&D, Axxelent Pharma Science
VP - Quality Assurance, Navitas Life Sciences
AGM - Quality, Bafna Pharmaceuticals
Sr Executive - Business Development, Cilicant
Pharma Consultant & CEO, Technology Business Incubator
Sr Manager – Business Development, Ami Polymer
President - Technical, Medopharm
MD, Bafna Pharma
GM - R&D, Balaji Research Service Providers
Director, Acumen Pharmaceuticals
MD, Omega Scientific Instruments
Technical Expert, Sigachi Industries
Leaders & experts from:
R&D
Quality
Packaging
Procurement & Supply Chain
Operations
Manufacturing
Network with influencers
Connect with CXOs, Plant Heads, Department Heads, and Senior Professionals from key domains to forge partnerships and explore new avenues for growth.
Stay ahead
Discover the latest industry trends, innovations, and developments to stay one step ahead in the dynamic pharma landscape.
Showcase your brand
Maximise visibility and demonstrate thought leadership by becoming a Partner/Sponsor. Reach influential industry leaders and potential clients.
Rajesh Bhatkal (Sales) - +91 9821313017 | [email protected]
Viveka Roychowdhury (Editorial) - +91 9819539759 | [email protected]
FOR DELEGATE REGISTRATIONS
Muhurta Shinde - +91 7303113133 | [email protected]
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
